V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320004833 | 320003239 | 0 | 76.8 | Neo-adjuvant (N) | 2016-08-15 | 2016-09-14 | Cisplatin | N | Y | 320014215 | CISPLATIN |
| 320004834 | 320003240 | 1.77 | 102 | Curative (C) | 2015-09-07 | 2015-09-07 | CISPLATIN + RT | 02 | N | 320014226 | CISPLATIN + RT |
| 320004835 | 320003240 | 1.67 | 81 | Curative (C) | 2018-01-06 | 2018-02-23 | CISPLATIN + RT | N | N | 320014226 | CISPLATIN + RT |
| 320004836 | 320003241 | 1.74 | null | Curative (C) | 2014-12-29 | 2015-01-11 | CISPLATIN + RT | 02 | N | 320014238 | CISPLATIN + RT |
| 320004837 | 320003241 | 1.7 | 75 | Neo-adjuvant (N) | 2014-12-31 | 2015-01-01 | Cisplatin 100 + RT(H&N) 1 day | N | N | 320014238 | CISPLATIN + RT |
| 320004838 | 320003242 | 1.7 | null | Curative (C) | 2016-11-09 | 2016-12-12 | Cisplatin | N | N | 320014249 | CISPLATIN |
| 320004839 | 320003242 | 1.69 | 118.4 | Not known (9) | 2018-06-08 | 2018-07-19 | CISPLATIN + FLUOROURACIL | null | Y | 320014249 | CISPLATIN + FLUOROURACIL |
| 320004840 | 320007033 | 1.89 | 71.2 | Adjuvant (A) | 2017-08-04 | 2017-08-12 | Cisplatin 100 + RT(H&N) 1 day | N | N | 320014251 | CISPLATIN + RT |
| 320004841 | 320007033 | 1.91 | 79.7 | Adjuvant (A) | 2016-06-15 | 2016-06-15 | Liposomal Doxorubicin 40mg/m2 | null | null | 320014251 | LIPOSOMAL DOXORUBICIN |
| 320004842 | 320005476 | 1.74 | null | Palliative (P) | 2017-09-17 | 2017-10-04 | Liposomal Doxorubicin 50mg/m2 | 02 | N | 320014258 | LIPOSOMAL DOXORUBICIN |
| 320004843 | 320005476 | 1.65 | 54 | Curative (C) | 2013-10-29 | 2013-11-05 | Trial Unspecified | N | N | 320014258 | TRIAL |
| 320004844 | 320005476 | 1.57 | 70.05 | Adjuvant (A) | 2018-03-06 | 2018-03-10 | CETUXIMAB | 02 | N | 320014258 | CETUXIMAB |
| 320004845 | 320003246 | 1.72 | null | Adjuvant (A) | 2017-05-13 | 2017-05-18 | Cetuximab 7 day (>Cycle 2) | N | N | 320014264 | CETUXIMAB |
| 320004846 | 320003247 | 1.66 | 64.7 | Curative (C) | 2017-03-31 | 2017-06-13 | Cisplatin + Radiotherapy | N | N | 320014273 | CISPLATIN + RT |
| 320004847 | 320003248 | 1.68 | 118.4 | Palliative (P) | 2018-06-20 | 2018-06-20 | Carboplatin + Liposomal Doxorubicin | 02 | N | 320014275 | CARBOPLATIN + LIPOSOMAL DOX |
| 320004848 | 320003249 | 1.77 | 67.2 | Adjuvant (A) | null | 2018-06-13 | CETUXIMAB | N | Y | 320014276 | CETUXIMAB |
| 320004849 | 320003249 | 1.68 | 70.8 | Curative (C) | 2017-12-28 | 2018-01-03 | Trial Unspecified | N | Y | 320014276 | TRIAL |
| 320004850 | 320003249 | 1.88 | 84.7 | Palliative (P) | 2017-11-25 | 2017-12-02 | Liposomal Doxorubicin 50mg/m2 | 2 | N | 320014276 | LIPOSOMAL DOXORUBICIN |
| 320004851 | 320003251 | 1.79 | 81 | Palliative (P) | 2015-07-13 | 2016-04-07 | Carboplatin + Liposomal Doxorubicin | N | N | 320014292 | CARBOPLATIN + LIPOSOMAL DOX |
| 320004852 | 320005480 | 1.66 | 60 | Palliative (P) | 2016-02-21 | 2016-03-08 | Carboplatin + Liposomal Doxorubicin | N | N | 320014293 | CARBOPLATIN + LIPOSOMAL DOX |
| 320004853 | 320005480 | 1.72 | 75.6 | Curative (C) | 2017-09-02 | 2017-10-17 | CISPLATIN + RT | 02 | Y | 320014293 | CISPLATIN + RT |
| 320004854 | 320003253 | 1.65 | 88.6 | Palliative (P) | 2018-12-05 | 2018-12-05 | Carboplatin + Liposomal Doxorubicin | N | Y | 320014301 | CARBOPLATIN + LIPOSOMAL DOX |
| 320004855 | 320003254 | 1.75 | 71.1 | Curative (C) | 2017-08-27 | 2017-08-27 | Trial Unspecified | N | N | 320014301 | TRIAL |
| 320004856 | 320003255 | null | 118.4 | Palliative (P) | 2016-01-24 | 2016-02-02 | GemCarbo Days 1+8 | N | Y | 320014313 | GEMCARBO |
| 320004857 | 320006531 | 1.67 | 112.05 | Disease modification (D) | 2015-12-18 | 2015-12-27 | EW EuroEwing 2012 Arm B IE | N | Y | 320014317 | TRIAL |
| 320004858 | 320003256 | 1.65 | 67.3 | Palliative (P) | 2016-10-07 | 2017-02-24 | Trial Unspecified | N | Y | 320014317 | TRIAL |
| 320004859 | 320003257 | 1.65 | 60 | Palliative (P) | 2016-06-14 | 2016-07-09 | Liposomal Doxorubicin (Caelyx) | N | N | 320014331 | LIPOSOMAL DOXORUBICIN |
| 320004860 | 320005484 | 1.98 | 79.7 | Curative (C) | 2013-07-27 | 2013-08-17 | Cetuximab 7 day (Cycle 1) | N | N | 320014334 | CETUXIMAB |
| 320004861 | 320005484 | 1.72 | 65.3 | Palliative (P) | 2017-12-16 | 2017-12-30 | Cisplatin +Fluorouracil (3 wk) | 02 | null | 320014334 | CISPLATIN + FLUOROURACIL |
| 320004862 | 320005484 | 1.57 | 81 | Adjuvant (A) | 2017-11-13 | 2017-11-14 | CARBOPLATIN + GEMCITABINE | 2 | N | 320014334 | GEMCARBO |
| 320004863 | 320003259 | 1.63 | null | Adjuvant (A) | 2016-04-30 | 2016-05-07 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 320014339 | CISPLATIN + RT |
| 320004864 | 320003259 | null | 75.6 | Palliative (P) | null | 2014-11-27 | GemCarbo Days 1+8 | N | Y | 320014339 | GEMCARBO |
| 320004865 | 320007374 | 1.75 | 77.35 | Palliative (P) | 2019-05-13 | 2019-05-17 | Carboplatin + Liposomal Doxorubicin | N | N | 320014344 | CARBOPLATIN + LIPOSOMAL DOX |
| 320004866 | 320003260 | 1.61 | 94.8 | Palliative (P) | 2015-07-28 | 2015-07-29 | CARBOPLATIN + GEMCITABINE | N | N | 320014349 | GEMCARBO |
| 320004867 | 320003260 | 1.3 | null | Palliative (P) | null | 2015-11-20 | CETUXIMAB | N | N | 320014349 | CETUXIMAB |
| 320004868 | 320006536 | 1.76 | 62 | Curative (C) | 2016-10-27 | 2016-11-10 | Cetuximab 7 day (>Cycle 2) | 02 | N | 320014364 | CETUXIMAB |
| 320004869 | 320003264 | 1.66 | 75 | Palliative (P) | 2018-04-28 | 2018-05-01 | Trial Unspecified | N | null | 320014368 | TRIAL |
| 320004870 | 320006537 | 1.82 | null | Adjuvant (A) | 2016-08-07 | 2016-08-21 | CNS LGG | 2 | N | 320014377 | NOT MATCHED |
| 320004871 | 320003266 | 1.69 | 77.35 | Palliative (P) | 2016-03-19 | 2016-04-02 | Carboplatin + Liposomal Doxorubicin | N | N | 320014382 | CARBOPLATIN + LIPOSOMAL DOX |
| 320004872 | 320003267 | 1.86 | 90 | Palliative (P) | 2018-02-16 | 2018-02-28 | Carboplatin + Liposomal Doxorubicin | 02 | N | 320014385 | CARBOPLATIN + LIPOSOMAL DOX |
| 320004873 | 320005489 | 1.7 | null | Adjuvant (A) | 2016-12-05 | 2017-05-19 | GemCarbo Days 1+8 | 02 | N | 320014385 | GEMCARBO |
| 320004874 | 320003269 | 1.84 | 97.2 | Adjuvant (A) | 2017-08-24 | 2017-09-19 | Cisplatin | N | N | 320014393 | CISPLATIN |
| 320004875 | 320003269 | 1.59 | null | null | null | 2017-03-05 | Cisplatin | N | N | 320014393 | CISPLATIN |
| 320004876 | 320007040 | 1.74 | 87.15 | Palliative (P) | 2013-10-05 | 2013-10-13 | GemCarbo Days 1+8 | N | null | 320014410 | GEMCARBO |
| 320004877 | 320003271 | 1.54 | 70 | Palliative (P) | 2018-06-07 | 2018-06-08 | Carboplatin + Liposomal Doxorubicin | 2 | N | 320014411 | CARBOPLATIN + LIPOSOMAL DOX |
| 320004878 | 320005491 | 1.84 | 68.6 | Adjuvant (A) | 2016-12-25 | 2017-02-11 | Trial Unspecified | N | Y | 320014418 | TRIAL |
| 320004879 | 320003274 | 1.67 | 78.2 | Curative (C) | 2016-08-06 | 2016-09-26 | Cisplatin + Radiotherapy | 2 | N | 320014420 | CISPLATIN + RT |
| 320004880 | 320003275 | 1.5 | 73.05 | Adjuvant (A) | 2016-05-06 | 2016-05-06 | Trial Unspecified | 02 | N | 320014420 | TRIAL |
| 320004881 | 320003277 | 1.63 | 64 | Curative (C) | 2017-05-17 | 2017-05-24 | Cisplatin 100 + RT(H&N) 1 day | N | N | 320014421 | CISPLATIN + RT |
| 320004882 | 320003278 | 1.69 | 24.6 | Curative (C) | 2017-09-15 | 2017-10-05 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 320014426 | CISPLATIN + RT |